Precision oncology has entered a new phase, as data sets mature and a new wave of tools emerges to help clinicians manage ...

In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of ...

Affidea also joins b-rayZ as a strategic investor, validating its vision, strengthening its market position and creating collaboration opportunities to drive innovation and growth ...

AI is fundamental to the competitive strategies of the most advanced healthcare and pharmaceutical firms. Here is how they ...

The alliance revolves around an AI-powered radiology analysis service for the development and evaluation of AI in medical imaging, with the aim of improving detection rates, speeding up treatment ...

A technological revolution is unfolding — one that will transform our world in ways we can barely comprehend. As artificial ...

The aim of the pilot is to scan and review more than 250,000 images generated at clinics in the Greater Manchester Cancer Alliance, to see if Qure.ai's qXR software can make faster and more ...

Detailed price information for Treatment.com Ai Inc (TRUE-CN) from The Globe and Mail including charting and trades.

Glenmark Pharmaceuticals Ltd's shares soared over 14% after announcing a deal with AbbVie worth up to USD 2 billion. The ...

This week, our host Lauren Goode, along with two of our senior writers, Kate Knibbs and Paresh Dave, dive into the show’s ...

Read more from Frieden on how Kennedy’s tactics are straight from the anti-vaccine playbook.